Retinal Dystrophies (DBCOND0056471)

Identifiers

Synonyms
Dystrophy, Retinal / Retinal dystrophy / Retinal dystrophy (disorder)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT04690062
BEOVU in the Treatment of Dystrophy-related Macular Neovascular Degenerationtreatment4unknown_status
NCT04545736
Oral Metformin for Treatment of ABCA4 Retinopathytreatment1 / 2recruiting
NCT05130385
High Resolution Optical Coherence TomographyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05820100
Observational Study to Assess the Reliability and Validity of the MLYMT and MLSDTNo drug interventionsNot AvailableNot Availablecompleted
NCT05902962
SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy SubjectsNo drug interventionstreatment1recruiting
NCT06319872
The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients with Retinal Degenerationtreatment1not_yet_recruiting
NCT05294978
EyeConic: Qualification for Cone-OptogeneticsNo drug interventionsNot AvailableNot Availablerecruiting
NCT05573984
Natural History of PRPF31 Mutation-Associated Retinal DystrophyNo drug interventionsNot AvailableNot Availablerecruiting
NCT04855045
An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene.treatment2 / 3unknown_status
NCT02983305
Optical Head-Mounted Display Technology for Low Vision RehabilitationNo drug interventionstreatmentNot Availablecompleted
NCT06162585
Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE StudyNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT02014389
Evaluation of Objective Perimetry Using Chromatic Multifocal PupillometerNo drug interventionsNot AvailableNot Availablerecruiting
NCT04945772
Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]No drug interventionstreatment2completed
NCT06177977
SS-HH-OCT as a Novel Diagnostic Modality for Early-Onset Retinal Dystrophies (EORDs)No drug interventionsotherNot Availablerecruiting
NCT03853252
iPS Cells of Patients for Models of Retinal DystrophiesNo drug interventionsotherNot Availablerecruiting
NCT03592017
Performance of Long-wavelength Autofluorescence ImagingNo drug interventionsdiagnosticNot Availablecompleted
NCT06455826
MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)No drug interventionstreatment1not_yet_recruiting
NCT04123626
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Genetreatment1 / 2active_not_recruiting
NCT03763227
Intravitreal Ranibizumab (Lucentis®) in the Treatment of Non-leaking Macular Cysts in Retinal Dystrophytreatment2completed
NCT03843840
Dual Wavelength OCTNo drug interventionsNot AvailableNot Availablecompleted
NCT01546181
Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General DiseasesNo drug interventionsNot AvailableNot Availablecompleted